# FDA Inspection 1249942 - Travere Therapeutics, Inc. - September 12, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/travere-therapeutics-inc/df40afcb-b5fe-4fb2-9bbb-e82d1d0a6f87
Source feed: FDA_Inspections

> FDA Inspection 1249942 for Travere Therapeutics, Inc. on September 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249942
- Company Name: Travere Therapeutics, Inc.
- Inspection Date: 2024-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1249942 - 2024-09-12](https://www.globalkeysolutions.net/records/fda_inspections/travere-therapeutics-inc/45cd4adb-a4ad-4e7e-8f22-5efc5697366d)
- [FDA Inspection 1174875 - 2022-06-23](https://www.globalkeysolutions.net/records/fda_inspections/travere-therapeutics-inc/a8c1cd96-53ec-4b93-8a40-716f162c37a8)

Company: https://www.globalkeysolutions.net/companies/travere-therapeutics-inc/a6c4209e-7c15-4a5f-9ff2-8ab137141d41

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c